2A Biosciences

Advancing towards human clinical trials through IND-enabling studies.

Breakthrough nerve regeneration through promotion of nerve growth factor and neuroplasticity. Extremely potent at small concentrations of drugs. Huge potential across therapeutic areas and diseases.

4 IND enabling development programs experience and 10 clinical trials run. Ex-Alcon and big pharma. Launched 2A Biosciences' ophthalmology program.

Raised $5.25M from leading psychedelic investors and family offices.